HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

7-epi-nemorosone from Clusia rosea induces apoptosis, androgen receptor down-regulation and dysregulation of PSA levels in LNCaP prostate carcinoma cells.

Abstract
The aim of this work was to characterize the antitumoral activity of the plant compound 7-epi-nemorosone in prostate carcinoma cell lines. Prostate cancer is the most frequently diagnosed malignancy and the second-leading cause of cancer death in men. In spite of the current therapeutic options for this cancer entity, many patients die due to metastases in distant organs and acquired chemotherapy resistance. Thus, approaches to provide improvements in outcome and quality of life for such patients are urgently needed. Recently, the polyisoprenylated benzophenone 7-epi-nemorosone, originally collected by honeybees from Clusia rosea and Clusia grandiflora (Clusiaceae), has been described to be a potent antitumoral agent. Here, its activity in prostate carcinoma is reported. 7-epi-nemorosone was isolated from Caribbean propolis employing RP-HPLC techniques. Its cytotoxicity was assessed using the MTT proliferation assay in human androgen-dependent prostate carcinoma LNCaP cells including an MDR1(+) sub-line. No cross-resistance was detected. FACS-based cell cycle analysis revealed a significant increase in the sub-G0/G1, G1, and depletion in the S phase populations. A concomitant down-regulation of cyclins D1/D3 and CDK 4/6 in LNCaP cells was detected by Western blot. Annexin-V-FITC labeling and caspase-3 cleavage assays showed that 7-epi-nemorosone induced apoptotic events. Major signal transduction elements such as p38 MAPK and Akt/PKB as well as androgen receptor AR and PSA production were found to be down-regulated after exposure to the drug. ERK1/2 protein levels and phosphorylation status were down-regulated accompanied by up-regulation but inhibition of the activity of their immediate upstream kinases MEK1/2. Additionally, Akt/PKB enzymatic activity was effectively inhibited at a similar concentration as for MEK1/2. Here, we demonstrate for the first time that 7-epi-nemorosone exerts cytotoxicity in an androgen-dependent prostate carcinoma entity by targeting the MEK1/2 signal transducer.
AuthorsDavid Díaz-Carballo, Sebastian Gustmann, Ali Haydar Acikelli, Walter Bardenheuer, Helmut Buehler, Holger Jastrow, Suleyman Ergun, Dirk Strumberg
JournalPhytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine) Vol. 19 Issue 14 Pg. 1298-306 (Nov 15 2012) ISSN: 1618-095X [Electronic] Germany
PMID22981203 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier GmbH. All rights reserved.
Chemical References
  • Androgens
  • Antineoplastic Agents, Phytogenic
  • Benzophenones
  • Cyclins
  • Plant Extracts
  • Receptors, Androgen
  • nemorosone
  • Propolis
  • Proto-Oncogene Proteins c-akt
  • Mitogen-Activated Protein Kinases
  • KLK3 protein, human
  • Kallikreins
  • Prostate-Specific Antigen
Topics
  • Androgens (metabolism)
  • Animals
  • Antineoplastic Agents, Phytogenic (isolation & purification, pharmacology, therapeutic use)
  • Apoptosis (drug effects)
  • Bees
  • Benzophenones (isolation & purification, pharmacology, therapeutic use)
  • Carcinoma (drug therapy, metabolism)
  • Cell Cycle (drug effects)
  • Cell Line, Tumor
  • Clusia (chemistry)
  • Cyclins (metabolism)
  • Down-Regulation
  • Drug Resistance, Multiple (drug effects)
  • Humans
  • Kallikreins (metabolism)
  • Male
  • Mitogen-Activated Protein Kinases
  • Phosphorylation
  • Phytotherapy
  • Plant Extracts (chemistry, pharmacology, therapeutic use)
  • Propolis (chemistry)
  • Prostate (drug effects, metabolism)
  • Prostate-Specific Antigen (metabolism)
  • Prostatic Neoplasms (drug therapy, metabolism)
  • Proto-Oncogene Proteins c-akt
  • Receptors, Androgen (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: